Compare FEMY & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEMY | ZDAI |
|---|---|---|
| Founded | 2004 | 2022 |
| Country | United States | Hong Kong |
| Employees | 54 | N/A |
| Industry | Medical/Dental Instruments | General Bldg Contractors - Nonresidential Bldgs |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 9.6M |
| IPO Year | 2021 | 2023 |
| Metric | FEMY | ZDAI |
|---|---|---|
| Price | $1.40 | $1.15 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 103.5K | 5.1K |
| Earning Date | 11-13-2026 | 08-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,293,313.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $328.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.77 | N/A |
| 52 Week Low | $0.29 | $0.20 |
| 52 Week High | $6.29 | $11.48 |
| Indicator | FEMY | ZDAI |
|---|---|---|
| Relative Strength Index (RSI) | 28.99 | 35.81 |
| Support Level | $0.37 | $0.34 |
| Resistance Level | $3.21 | $1.77 |
| Average True Range (ATR) | 0.17 | 0.11 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 17.65 | 4.55 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.